Posted 1/15/2008 1:00 PM (GMT 0)
Salix Pharmaceuticals, Ltd. SLXP today announced that, pursuant to a supply and distribution agreement with Watson Pharma, Inc., Watson will market and sell an authorized generic of COLAZAL(R) (balsalazide disodium) Capsules 750 mg, the Company's anti-inflammatory drug approved for the treatment of mildly to moderately active ulcerative colitis. Watson will launch the authorized generic product immediately. December 28, 2007 article
http://news.moneycentral.msn.com/ticker/article.aspx?symbol=US:SLXP&feed=BW&date=20071228&id=7983368
So I'm assuming they're just waiting for the distribution agreement. So it should be any day now!